BioVenture VoiCes with Chris Garabedian cover image

Episode 28: Hatteras Venture Partners' Clay Thorp

BioVenture VoiCes with Chris Garabedian

00:00

Histosonics: long-term portfolio success

Clay narrates Histosonics' 2009 Series A, pivots, regulatory approvals, and its $2.25B sale and concurrent growth financing.

Play episode from 49:47
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app